MEDITECH(SH:603990)2019-04-26 16:00Financial Performance - Operating revenue increased by 12.56% to CNY 40,950,266.98 compared to the same period last year[6] - Net loss attributable to shareholders decreased from CNY 7,121,798.25 to CNY 4,705,884.30, a reduction of approximately 33.5%[6] - Total operating revenue for Q1 2019 was CNY 40,950,266.98, an increase of 15.5% compared to CNY 36,379,413.40 in Q1 2018[25] - Net loss for Q1 2019 was CNY 4,329,860.88, compared to a net loss of CNY 4,907,314.78 in Q1 2018, showing an improvement of 11.7%[26] - Operating profit for Q1 2019 was CNY -4,192,272.90, slightly better than the operating loss of CNY -5,454,926.29 in Q1 2018[25] - Basic and diluted earnings per share for Q1 2019 were both CNY -0.05, unchanged from Q1 2018[26] - The net profit for Q1 2019 was ¥1,508,600.58, compared to a net loss of ¥774,704.04 in Q1 2018, indicating a significant turnaround[29] - The total operating profit for Q1 2019 was ¥1,648,584.13, compared to a loss of ¥1,309,926.05 in the same period last year[28] Cash Flow - Cash flow from operating activities showed a loss of CNY 47,154,974.19, worsening from a loss of CNY 35,674,640.59 in the previous year[6] - Net cash flow from operating activities decreased by 11,480,300 RMB, a decline of 32.18%, mainly due to increased guarantee deposits, management expenses, and sales expenses compared to the previous year[13] - Net cash flow from investing activities decreased by 97,771,400 RMB, a drop of 132.99%, primarily due to payments for equity purchase intentions and a decrease in redeemed financial products compared to the previous period[13] - Net cash flow from financing activities decreased by 9,947,000 RMB, a reduction of 108.44%, mainly due to repayments of short-term bank loans in the current period[13] - Cash inflow from operating activities for Q1 2019 was CNY 56,048,975.75, an increase of 25.8% compared to CNY 44,519,453.67 in Q1 2018[34] - Net cash flow from operating activities for Q1 2019 was -CNY 35,761,607.23, worsening from -CNY 27,371,625.56 in Q1 2018[34] - The company reported a total cash outflow from operating activities of CNY 91,810,582.98 in Q1 2019, compared to CNY 71,891,079.23 in Q1 2018[34] Assets and Liabilities - Total assets decreased by 7.72% to CNY 661,842,494.72 compared to the end of the previous year[6] - Total current assets as of March 31, 2019, amounted to 402,837,755.12 RMB, down from 454,280,203.03 RMB at the end of 2018[16] - Total assets as of March 31, 2019, were 661,842,494.72 RMB, compared to 717,212,623.80 RMB at the end of 2018[18] - Total liabilities as of March 31, 2019, were 193,025,586.27 RMB, down from 244,055,145.04 RMB at the end of 2018[18] - Total equity attributable to shareholders as of March 31, 2019, was 468,251,042.82 RMB, compared to 472,361,471.96 RMB at the end of 2018[18] - Total liabilities for Q1 2019 were CNY 233,590,798.36, a decrease from CNY 281,992,584.44 in Q1 2018[22] - Total equity for Q1 2019 was CNY 461,033,269.06, slightly up from CNY 459,535,377.91 in Q1 2018[22] Shareholder Information - The number of shareholders reached 3,562 at the end of the reporting period[8] Expenses - Cash and cash equivalents decreased by 40.57% to CNY 68,407,000.00, primarily due to operational expenditures and construction payments[11] - Other receivables increased by 55.19% to CNY 37,000,000.00, mainly due to payments for equity purchase intentions[11] - Financial expenses decreased by 369.35% to CNY -201,240.00, attributed to reduced foreign exchange losses[12] - Operating income for the current period is 0, compared to 478,200 RMB in the previous period, mainly due to the absence of government subsidies unrelated to the company's daily operations[13] - Income tax expenses increased by 206,900 RMB, a rise of 298.36%, primarily due to higher income tax expenses for the parent company[13] - Research and development expenses for Q1 2019 were CNY 13,862,016.35, compared to CNY 13,752,145.42 in Q1 2018, indicating a stable investment in innovation[25] - Research and development expenses for Q1 2019 were ¥10,796,893.78, slightly down from ¥11,538,311.63 in Q1 2018[28]